
Topic
Radiation Oncology
37 Podcasts • 14 Cases • 6 Courses on BackTable
Hear how experienced clinicians in Radiation Oncology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Episode # 297 • 07 Apr 2026
How Prostate Artery Embolization Optimizes Radiation Outcomes
What role does prostate artery embolization (PAE) play in modern prostate cancer care? In this episode of BackTable Urology, Dr. Nainesh Parikh (Interventional Radiology at Moffitt Cancer Center) and Dr. Kosj Yamoah (Radiation Oncology at Moffitt Cancer Center) join Dr. Ruchika Talwar (Vanderbilt University) to discuss how PAE could become a key adjunct in optimizing radiation therapy outcomes.
More on Radiation Oncology
Loading recent podcasts…
Urology Episode #297
Apr 7, 2026
with Dr. Nainesh Parikh, Dr. Kosj Yamoah, Dr. Ruchika Talwar
What role does prostate artery embolization (PAE) play in modern prostate cancer care? In this episode of BackTable...
1,900+ listens
Tumor Board Episode #48
Feb 17, 2026
with Dr. Erika Hamilton, Dr. Lindsay Peterson
In a patient with metastatic HER2-positive breast cancer, what should guide the next decision: trial data, toxicity, or...
260+ listens
Tumor Board Episode #45
Jan 27, 2026
with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...
220+ listens
VI Episode #603
Jan 2, 2026
with Dr. Robert Suh, Dr. Alan Lee, Dr. Scott Oh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might simultaneous ablation and biopsy be the new standard for high-probability lung cancer cases where surgery...
1,300+ listens
Tumor Board Episode #50
Mar 10, 2026
with Dr. Ryan Funk, Dr. Dustin Boothe
Though relatively new, there is a rapidly growing interest in the field of therapeutic radiopharmaceuticals and their...
440+ listens
Urology Episode #287
Jan 30, 2026
with Dr. Amanda Nizam, Dr. Brad McGregor, Dr. Alan Tan
Is the era of cisplatin over, or are we simply becoming more precise about who benefits from it? As perioperative...
1,400+ listens
Tumor Board Episode #42
Jan 6, 2026
with Dr. Rebecca Snyder, Dr. Jonathan Mizrahi
For the small subset of pancreatic cancer patients whose cancer is detected early and remains localized, there are now...
260+ listens
VI Episode #599
Dec 19, 2025
with Dr. Scott Oh, Dr. Alan Lee, Dr. Robert Suh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Collaboration between interventional radiology and radiation oncology has enabled high-dose brachytherapy in central...
1,300+ listens
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
VI Case
Nov 21, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee
VI Case
Nov 21, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 17, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
VI Case
Nov 21, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Nov 11, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.






